|
MechanismGABAA receptor agonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date20 Dec 1985 |
100 Clinical Results associated with B. Braun Australia Pty Ltd.
0 Patents (Medical) associated with B. Braun Australia Pty Ltd.
100 Deals associated with B. Braun Australia Pty Ltd.
100 Translational Medicine associated with B. Braun Australia Pty Ltd.